This mechanism aligns with reports that PARP inhibitors, CHK1 inhibitors (64), and conventional chemotherapeutics like cisplatin and gemcitabine can activate STING through cytosolic dsDNA accumulation in various cancers (39). The gene discussed is CHEK1; the disease is cancer.